Integrated Suicide & Trauma Therapy for Suicide Risk
- Sponsor
- Unity Health Toronto
- Study ID
- NCT05613972
- Status
- Recruiting
Conditions
- Major Depressive Disorder
- Suicide
- Trauma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Integrated Suicide and Trauma Therapy — OTHER12-week trauma therapy for suicide risk
Study Details
The investigators have developed a novel suicide intervention, Integrated Suicide and Trauma Therapy (ISTT). ISTT combines Brief-Skills for Safer Living (Brief-SfSL)-a promising method to enhance coping skills and reduce suicidality-with a trauma therapy component to alleviate the specific impacts of childhood trauma on suicide risk. The aim of this pilot is to test 12-weeks of ISTT to alleviate suicide risk among individuals with a history of childhood trauma and current suicidality.
Key Dates
- First listed
- Nov 14, 2022
- Start date
- Dec 8, 2025
- Status verified
- Dec 2025
- Primary completion
- Apr 30, 2026
- Completion
- Apr 30, 2027
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Integrated Suicide and Trauma Therapy (BSTT)This novel suicide intervention integrates Brief Skills for Safer Learning (B-SfSL) with trauma therapy. ISTT incorporates the guiding principles of taking a non-pathologizing approach to treatment, emphasizing safety, attending to the therapeutic relationship, empowering clients, and incorporating solution-focused concepts.
Primary Outcome Measure
Change in Beck Scale for Suicide Ideation (BSS) score [ Time Frame: From baseline to 1 week post-therapy ]
Central Contacts
- Sakina Rizvi, PhD,MACP,RP416-864-6060
- Aleksandra Lalovic, PhD,MEd,RP416-864-6060
Find similar trials
Related Studies
- Study of Neuro-Cognitive Correlates of Pediatric Anxiety DisordersPHASE2 · Recruiting · National Institute of Mental Health (NIMH) · Bethesda, Maryland
- Reaching Out to Distressed Medical Residents, Fellows and FacultyRecruiting · Oregon Health and Science University · Portland, Oregon
- REVIVE: Reducing Exsanguination Via In-Vivo Expandable FoamRecruiting · Arsenal Medical, Inc. · Birmingham, Alabama
- Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive DisorderPHASE1 · Recruiting · National Institute of Mental Health (NIMH) · Bethesda, Maryland